ISO 14117:2019
p
ISO 14117:2019
73915
недоступно на русском языке

This document specifies test methodologies for the evaluation of the electromagnetic compatibility (EMC) of active implantable cardiovascular devices that provide one or more therapies for bradycardia, tachycardia and cardiac resynchronization in conjunction with transvenous lead systems.

NOTE This document was designed for pulse generators used with endocardial leads or epicardial leads. At the time of this edition, the authors recognized the emergence of technologies that do not use endocardial leads or epicardial leads for which adaptations of this part will be required. Such adaptations are left to the discretion of manufacturers incorporating these technologies.

It specifies performance limits of these devices, which are subject to interactions with EM emitters operating across the EM spectrum in the two following ranges:

— 0 Hz ≤ ? < 385 MHz;

— 385 MHz ≤ ? ≤ 3 000 MHz

This document also specifies requirements for the protection of these devices from EM fields encountered in a therapeutic environment and defines their required accompanying documentation, providing manufacturers of EM emitters with information about their expected level of immunity.


Общая информация 

  •  :  Published
     : 2019-09
  •  : 2
  •  : ISO/TC 150/SC 6 Active implants
  •  :
    11.040.40 Implants for surgery, prosthetics and orthotics
    33.100.01 Electromagnetic compatibility in general

Цели в области устойчивого развития

Данный стандарт разработан для достижения следующих Цель устойчивого развития:

Приобрести данный стандарт

ru
Формат Язык
std 1 198 PDF + ePub
std 2 198 Бумажный
  • CHF198

Жизненный цикл


Появились вопросы?

Ознакомьтесь с FAQ

Работа с клиентами
+41 22 749 08 88

Часы работы:
Понедельник – пятница: 09:00-12:00, 14:00-17:00 (UTC+1)

Будьте в курсе актуальных новостей ИСО

Подписывайтесь на наши новости, обзоры, а также на информацию о продуктах.